Literature DB >> 3301483

Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus.

M L Olsson, G Sundkvist, A Lernmark.   

Abstract

The conventional indirect immunofluorescence test of islet cell antibodies was recently improved by the development of a two-colour immunofluorescence assay using a monoclonal proinsulin antibody to detect islet B cells. The aim of this study was to test whether in this new assay the prevalence and titre of ICA were affected by the time of incubation carried out in the presence of aprotinin (Trasylol) as an inhibitor of proteolysis. The end-point titre of ICA was therefore determined in sera from 70 children aged 0.6 to 15 years with recent onset Type 1 (insulin-dependent) diabetes mellitus, 50 healthy control subjects and 97 non-diabetic siblings of Type 1 diabetic children. In the conventional two-colour assay, ICA was positive in 53/70 (76%) Type 1 diabetic patients, 1/50 control subjects and 2/97 siblings after 30 min incubation. Prolonged incubation for 18 h increased the prevalence of ICA positive samples to 62/70 (89%) in the diabetic patients and to 2/50 in the control subjects, while the prevalence among the siblings was unchanged. Of the ICA positive non-diabetic subjects, one control child has a father with Type 1 diabetes, and one of the siblings subsequently developed Type 1 diabetes. In the diabetic patients the median titre was 1:32 for the 30 min incubation, and it increased to 1:64 for the 18 h incubation (p less than 0.001). A marked prozone effect was seen; 16% of the samples from the Type 1 diabetic children sera were negative at a 1:2 dilution, but were found positive at higher dilutions.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3301483     DOI: 10.1007/BF00299026

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  21 in total

1.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

2.  Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type.

Authors:  W J Irvine; C J McCallum; R S Gray; C J Campbell; L J Duncan; J W Farquhar; H Vaughan; P J Morris
Journal:  Diabetes       Date:  1977-02       Impact factor: 9.461

3.  Are insulin autoantibodies markers for insulin-dependent diabetes mellitus?

Authors:  M A Atkinson; N K Maclaren; W J Riley; W E Winter; D D Fisk; R P Spillar
Journal:  Diabetes       Date:  1986-08       Impact factor: 9.461

4.  A new method of detection of islet cell antibodies (ICA) using peroxidase-labeled protein A, and incidence of ICA in type 1 (insulin-dependent) diabetes.

Authors:  A Takahashi; M Tsujihata; A Yokota; Y Yamaguchi; Y Ueda; S Akazawa; S Miyake; S Nagataki
Journal:  Diabetologia       Date:  1986-06       Impact factor: 10.122

5.  A two-colour immunofluorescence test with a monoclonal human proinsulin antibody improves the assay for islet cell antibodies.

Authors:  O D Madsen; M L Olsson; G Bille; G Sundkvist; A Lernmark; G Dahlqvist; J Ludvigsson
Journal:  Diabetologia       Date:  1986-02       Impact factor: 10.122

6.  Clinical time-course and characteristics of islet cell cytoplasmatic antibodies in childhood diabetes.

Authors:  G J Bruining; J Molenaar; C W Tuk; J Lindeman; H A Bruining; B Marner
Journal:  Diabetologia       Date:  1984-01       Impact factor: 10.122

7.  Diffusion of C-peptide but not proinsulin from islets in frozen sections of human pancreas identified by monoclonal antibodies.

Authors:  O D Madsen; L I Larsson; A Lernmark
Journal:  Biomed Biochim Acta       Date:  1985

8.  Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage.

Authors:  G F Bottazzo; B M Dean; A N Gorsuch; A G Cudworth; D Doniach
Journal:  Lancet       Date:  1980-03-29       Impact factor: 79.321

9.  Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients.

Authors:  B Marner; T Agner; C Binder; A Lernmark; J Nerup; T Mandrup-Poulsen; S Walldorff
Journal:  Diabetologia       Date:  1985-12       Impact factor: 10.122

10.  Islet-cell antibodies in IDDM and NIDDM in a Japanese population.

Authors:  T Kobayashi; S Sawano; T Sugimoto; T Itoh; K Kosaka; T Tanaka; S Suwa
Journal:  Tohoku J Exp Med       Date:  1983-12       Impact factor: 1.848

View more
  22 in total

1.  The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies.

Authors:  M Maziarz; M Janer; J C Roach; W Hagopian; J P Palmer; K Deutsch; C B Sanjeevi; I Kockum; N Breslow; A Lernmark
Journal:  Genes Immun       Date:  2010-05-06       Impact factor: 2.676

2.  Relating homology between the Epstein-Barr virus BOLF1 molecule and HLA-DQw8 beta chain to recent onset type 1 (insulin-dependent) diabetes mellitus.

Authors:  T Sairenji; M Daibata; C H Sorli; H Qvistbäck; R E Humphreys; J Ludvigsson; J Palmer; M Landin-Olsson; G Sundkvist; B Michelsen
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

3.  Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis.

Authors:  M Wallensteen; G Dahlquist; B Persson; M Landin-Olsson; A Lernmark; G Sundkvist; B Thalme
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

4.  Antibodies to a Mr-64,000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes.

Authors:  M Christie; M Landin-Olsson; G Sundkvist; G Dahlquist; A Lernmark; S Baekkeskov
Journal:  Diabetologia       Date:  1988-08       Impact factor: 10.122

5.  Insulin autoantibodies are associated with islet cell antibodies; their relation to insulin antibodies and B-cell function in diabetic children.

Authors:  J Ludvigsson; C Binder; T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

6.  Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS).

Authors:  B Littorin; P Blom; A Schölin; H J Arnqvist; G Blohmé; J Bolinder; A Ekbom-Schnell; J W Eriksson; S Gudbjörnsdottir; L Nyström; J Ostman; G Sundkvist
Journal:  Diabetologia       Date:  2006-10-27       Impact factor: 10.122

7.  Preclinical and manifest diabetes mellitus in young patients with Friedreich's ataxia: no evidence of immune process behind the islet cell destruction.

Authors:  E J Schoenle; E J Boltshauser; S Baekkeskov; M Landin Olsson; T Torresani; A von Felten
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

8.  Inhibition of insulin secretion, but normal peripheral insulin sensitivity, in a patient with a malignant endocrine pancreatic tumour producing high amounts of an islet amyloid polypeptide-like molecule.

Authors:  M Stridsberg; C Berne; S Sandler; E Wilander; K Oberg
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

9.  Comparison of measurements of autoantibodies to glutamic acid decarboxylase and islet antigen-2 in whole blood eluates from dried blood spots using the RSR-enzyme linked immunosorbent assay kits and in-house radioimmunoassays.

Authors:  Anders Persson; Charlotte Becker; Ida Hansson; Anita Nilsson; Carina Törn
Journal:  Exp Diabetes Res       Date:  2010-06-03

Review 10.  Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus.

Authors:  A Lernmark; G Klöppel; D Stenger; C Vathanaprida; K Fält; M Landin-Olsson; D G Baskin; J P Palmer; A M Gown; J S Petersen
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.